SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (21754)5/9/1999 2:02:00 PM
From: RT  Respond to of 23519
 
BigK,

I agree, the safety profile of Viagara will not effect Muse sales unless the FDA pulls Viagra. The chances of that happening is about as remote as VLAD getting hit by lightning while on his computer.

RT



To: BigKNY3 who wrote (21754)5/9/1999 6:19:00 PM
From: VLAD  Read Replies (2) | Respond to of 23519
 
Are you still fixated on that big word you learned a while back?

Bottom line is that for almost one year now there has been no real marketing arm for MUSE domestically yet the product sells itself at a rate of 3 to 4k scripts a week.

The big question is how much can be sold if and when we get a domestic partner to detail MUSE to the PCP.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News